Empagliflozin ameliorates atherosclerosis via regulating the intestinal flora.
Saved in:
| Title: | Empagliflozin ameliorates atherosclerosis via regulating the intestinal flora. |
|---|---|
| Authors: | Hao, Han1 (AUTHOR), Li, Zhu1 (AUTHOR), Qiao, Shi-yang1 (AUTHOR), Qi, Yu1 (AUTHOR), Xu, Xiao-ying2 (AUTHOR), Si, Jia-yi2 (AUTHOR), Liu, Yi-hai1 (AUTHOR), Chang, Lei3 (AUTHOR), Shi, Yi-fan1 (AUTHOR), Xu, Biao1,4 (AUTHOR) xubiao62@nju.edu.cn, Wei, Zhong-hai1 (AUTHOR) weizhonghai@njglyy.com, Kang, Li-na1,4 (AUTHOR) kanglina@njglyy.com |
| Source: | Atherosclerosis (00219150). Apr2023, Vol. 371, p32-40. 9p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 162976904 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Empagliflozin ameliorates atherosclerosis via regulating the intestinal flora. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Hao%2C+Han%22">Hao, Han</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Zhu%22">Li, Zhu</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Qiao%2C+Shi-yang%22">Qiao, Shi-yang</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Qi%2C+Yu%22">Qi, Yu</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xu%2C+Xiao-ying%22">Xu, Xiao-ying</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Si%2C+Jia-yi%22">Si, Jia-yi</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Yi-hai%22">Liu, Yi-hai</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chang%2C+Lei%22">Chang, Lei</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shi%2C+Yi-fan%22">Shi, Yi-fan</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xu%2C+Biao%22">Xu, Biao</searchLink><relatesTo>1,4</relatesTo> (AUTHOR)<i> xubiao62@nju.edu.cn</i><br /><searchLink fieldCode="AR" term="%22Wei%2C+Zhong-hai%22">Wei, Zhong-hai</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> weizhonghai@njglyy.com</i><br /><searchLink fieldCode="AR" term="%22Kang%2C+Li-na%22">Kang, Li-na</searchLink><relatesTo>1,4</relatesTo> (AUTHOR)<i> kanglina@njglyy.com</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Atherosclerosis+%2800219150%29%22">Atherosclerosis (00219150)</searchLink>. Apr2023, Vol. 371, p32-40. 9p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=162976904 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.atherosclerosis.2023.03.011 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 9 StartPage: 32 Titles: – TitleFull: Empagliflozin ameliorates atherosclerosis via regulating the intestinal flora. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hao, Han – PersonEntity: Name: NameFull: Li, Zhu – PersonEntity: Name: NameFull: Qiao, Shi-yang – PersonEntity: Name: NameFull: Qi, Yu – PersonEntity: Name: NameFull: Xu, Xiao-ying – PersonEntity: Name: NameFull: Si, Jia-yi – PersonEntity: Name: NameFull: Liu, Yi-hai – PersonEntity: Name: NameFull: Chang, Lei – PersonEntity: Name: NameFull: Shi, Yi-fan – PersonEntity: Name: NameFull: Xu, Biao – PersonEntity: Name: NameFull: Wei, Zhong-hai – PersonEntity: Name: NameFull: Kang, Li-na IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 04 Text: Apr2023 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 00219150 Numbering: – Type: volume Value: 371 Titles: – TitleFull: Atherosclerosis (00219150) Type: main |
| ResultId | 1 |